Neogen Bundle
Who Owns Neogen Corporation?
Understanding Neogen's ownership is key to grasping its strategic direction and accountability. The company's journey includes a significant merger with 3M's Food Safety Division in September 2022, which altered its ownership structure.
Founded in 1982, Neogen has grown into a global leader in food and animal safety, offering a wide array of diagnostic tests and animal health products. Its commitment to innovation is evident in its product development, including solutions like the Neogen BCG Matrix.
As of fiscal year 2025, Neogen reported substantial growth, with revenues reaching $924.22 million, a 12.37% increase year-over-year. The company employs 2,974 individuals across 28 countries, underscoring its global reach and operational scale.
Who Founded Neogen?
Neogen Corporation was established in 1982 in Lansing, Michigan, by Herbert D. 'Ted' Doan and James L. Herbert. Its inception was rooted in a project by Michigan State University, designed to commercialize scientific advancements and foster the local biotechnology sector. This initiative received an initial investment of $50,000 from the Michigan State University Foundation, which was granted 30% of the company's shares in its early stages. The core vision was to leverage scientific innovation for practical applications in food and animal safety, while also retaining molecular biologists within Michigan.
Neogen was founded with a clear mission to apply scientific innovation to critical areas of food and animal safety. This focus guided its early development and subsequent growth strategies.
The university's foundation provided crucial early funding and ownership stake, underscoring a commitment to commercializing research and strengthening the state's biotech community.
An initial investment of $50,000 from the Michigan State University Foundation secured 30% of the company's equity early on. This support was instrumental in the company's launch.
Specific details on the initial equity split between founders Ted Doan and James Herbert are not publicly detailed. However, the significant stake held by the university foundation indicates a strong early partnership.
The company's early strategy included growth through acquisitions, as evidenced by its purchase of Ideal Instruments Inc. This demonstrated a proactive approach to expanding its market presence and capabilities.
The founding vision of applying scientific advancements to food and animal safety was central to Neogen's initial operations and continued expansion. This commitment to innovation remains a key aspect of its identity.
While precise details regarding the initial equity distribution between founders Herbert D. 'Ted' Doan and James L. Herbert are not readily available, the Michigan State University Foundation's early acquisition of 30% of the company's shares highlights a substantial initial investment and partnership. Information concerning early agreements like vesting schedules or buy-sell clauses is also not explicitly disclosed. The company's strategic direction was evident early on with its acquisition of Ideal Instruments Inc., signaling a commitment to growth through strategic purchases. The founders' vision of applying scientific innovation to food and animal safety was clearly embedded in the company's initial focus and subsequent development, a strategy that has been further explored in discussions on the Marketing Strategy of Neogen.
Neogen Corporation's early ownership was significantly shaped by its origins as a university-backed venture. The Michigan State University Foundation played a pivotal role, securing a substantial stake early in the company's history.
- Founded in 1982 by Herbert D. 'Ted' Doan and James L. Herbert.
- Initial investment of $50,000 from Michigan State University Foundation.
- Michigan State University Foundation held 30% of company shares early on.
- Focus on commercializing scientific innovations in food and animal safety.
Neogen SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Neogen’s Ownership Changed Over Time?
Neogen Corporation's ownership journey began with its public offering on August 23, 1989, trading on the NASDAQ under the ticker NEOG. A pivotal moment impacting its ownership structure was the acquisition of 3M's Food Safety Business in September 2022, which significantly altered the distribution of shares between pre-merger entities.
| Major Shareholder | Shares Held (as of March 31, 2025, unless otherwise noted) |
| BlackRock, Inc. | 31,559,156 |
| Vanguard Group Inc. | 23,550,128 |
| Norges Bank (as of December 31, 2024) | 17,477,007 |
| William Blair Investment Management, Llc (as of June 30, 2025) | 9,403,020 |
| Baillie Gifford & Co. | 9,158,876 |
| Gates Capital Management, Inc. | 9,156,922 |
| State Street Corp | 8,610,497 |
| T. Rowe Price Investment Management, Inc. | 8,458,494 |
| Dimensional Fund Advisors Lp | 8,435,969 |
The current Neogen ownership landscape is dominated by institutional investors, who collectively hold approximately 96.73% of the company's stock. Insiders represent about 1.13%, with public companies and individual investors holding the remaining portion. The acquisition of 3M's Food Safety Business in September 2022 resulted in a near 50/50 split between the shareholders of the two merging entities, with approximately 108.2 million new shares issued. This integration faced challenges, including a $461 million non-cash goodwill impairment charge reported in January 2025, which affected the company's financial performance and stock valuation, underscoring the significant impact of such large-scale transactions on Neogen's company structure and Neogen stock ownership.
Neogen Corporation's stock is primarily held by large financial institutions. This concentration of Neogen shareholders indicates significant institutional influence on the company's strategic decisions.
- Neogen is a publicly traded company on the NASDAQ.
- Institutional investors are the dominant Neogen corporation owners.
- The acquisition of 3M's Food Safety Business significantly altered Neogen's ownership percentages.
- Understanding Neogen ownership is key to analyzing its market position and Competitors Landscape of Neogen.
Neogen PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Neogen’s Board?
Neogen Corporation's governance is overseen by its Board of Directors, with James C. Borel serving as the Board Chair. The board is responsible for guiding the company's strategic direction and ensuring effective oversight. As of early 2025, the board includes directors with diverse expertise relevant to Neogen's operations.
| Director Name | Role | Appointment/Departure |
|---|---|---|
| James C. Borel | Board Chair | |
| Jeffrey D. Capello | Director | |
| Andrea Wainer | Director | Effective June 1, 2025 |
| William Boehm | Director | |
| Aashima Gupta | Director | |
| Thierry Bernard | Director | Effective November 1, 2024 |
| James P. Tobin | Former Director | Retired May 31, 2025 |
The voting power for Neogen Corporation's common stock operates on a one-share-one-vote basis. As of August 27, 2024, there were 216,698,138 shares of common stock outstanding, granting each shareholder a single vote per share on all matters, including director elections. Cumulative voting rights are not provided to common stock holders. The Board of Directors is structured into three classes, with each class serving a staggered three-year term. Recent governance discussions have been influenced by a class action lawsuit concerning the integration of the 3M Food Safety business, which alleged misrepresentations and material weaknesses in financial reporting as of November 30, 2024. These events highlight the importance of robust financial oversight and strategic decision-making, as detailed in discussions around the Growth Strategy of Neogen.
Neogen's Board of Directors is structured to ensure continuity and diverse expertise. Shareholder voting power is directly tied to the number of shares owned, with a one-share-one-vote principle in place.
- Board Chair: James C. Borel
- Staggered three-year terms for directors
- One-share-one-vote for shareholders
- No cumulative voting rights
- Recent governance scrutiny due to legal action
Neogen Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Neogen’s Ownership Landscape?
In recent years, Neogen Corporation has experienced significant shifts in its ownership structure and strategic focus. A pivotal moment was the acquisition of 3M's Food Safety Business in September 2022, which altered the distribution of Neogen's outstanding common stock. This transaction saw 3M stockholders gain a majority stake, holding approximately 50.1% of Neogen's shares immediately post-merger, while existing Neogen shareholders retained approximately 49.9%.
| Event | Date | Impact on Ownership |
|---|---|---|
| Acquisition of 3M's Food Safety Business | September 2022 | 3M stockholders acquired ~50.1% of Neogen's common stock |
| Sale of Cleaners and Disinfectants Business | July 2025 | Divestiture to focus on core food safety diagnostics |
| CEO Transition | August 11, 2025 | Mike Nassif appointed CEO and President |
Further strategic adjustments include the sale of its cleaners and disinfectants business to Kersia Group for $130 million in cash, finalized in July 2025. This move is designed to sharpen the company's focus on high-margin food safety diagnostics. The proceeds are earmarked for debt reduction, projected to decrease the net leverage ratio by about 0.4x on a pro forma basis. Leadership has also seen a change, with Mike Nassif stepping in as the new CEO and President on August 11, 2025, bringing extensive experience in diagnostics and global commercial operations.
The sale of the cleaners and disinfectants business in July 2025 for $130 million signals a clear pivot. This action aims to concentrate resources on core, high-margin food safety diagnostics.
Mike Nassif's appointment as CEO and President in August 2025 brings a wealth of experience in diagnostics. This leadership change aligns with Neogen's refined strategic direction.
The company reported a $461 million non-cash goodwill impairment charge in January 2025, linked to the 3M acquisition. Additionally, material weaknesses in internal control over financial reporting were noted as of November 30, 2024.
Capital expenditures are expected to decrease to approximately $50 million in fiscal year 2026. The company has a remaining share repurchase authorization of 5,900,000 shares and does not anticipate paying cash dividends in the near future.
Neogen Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Neogen Company?
- What is Competitive Landscape of Neogen Company?
- What is Growth Strategy and Future Prospects of Neogen Company?
- How Does Neogen Company Work?
- What is Sales and Marketing Strategy of Neogen Company?
- What are Mission Vision & Core Values of Neogen Company?
- What is Customer Demographics and Target Market of Neogen Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.